The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Vantin
Synonyms :
cefpodoxime
Class :
Cephalosporins, 3rd Generation
Brand Name :
Vantin
Synonyms :
cefpodoxime
Class :
Cephalosporins, 3rd Generation
Dosage Forms & Strengths
Oral suspension
50mg/5mL
100mg/5mL
Tablet
100mg
200mg
200
mg
Orally
every 12 hrs
10
days
Note: It is indicated for Acute Bronchitis & Acute Exacerbation of Chronic Bronchitis
200
mg
Orally
every 12 hrs
14
days
Note: It is indicated for Acute Community-Acquired Pneumonia.
Dosage Forms & Strengths
Oral suspension
50mg/5mL
100mg/5mL
Tablet
100mg
200mg
cefpodoxime: they may diminish the serum concentration of antacids
cefpodoxime: they may diminish the serum concentration of antacids
cefpodoxime: they may diminish the serum concentration of antacids
cefpodoxime: they may diminish the serum concentration of antacids
cefpodoxime: they may diminish the serum concentration of antacids
cefpodoxime: they may diminish the serum concentration of antacids
cefpodoxime: they may diminish the serum concentration of antacids
it may diminish the excretion rate when combined with estradiol valerate resulting in a greater serum level
When loracarbef is used together with cefpodoxime, the risk or seriousness of nephrotoxicity is enhanced
When cefpodoxime is used together with piroxicam, this leads to increased risk or seriousness of nephrotoxicity
When cefmenoxime is used together with cefpodoxime, this leads to enhanced risk or seriousness of nephrotoxicity
When cefpodoxime is used together with proglumetacin, this leads to enhanced risk or seriousness of nephrotoxicity
When cefpodoxime is used together with benoxaprofen, this leads to enhanced risk or seriousness of nephrotoxicity
cefpodoxime leads to a reduction in the rate of excretion of eucalyptus oil which leads to increased level of serum
When cefpodoxime is used together with aluminium phosphate, this leads to a reduction in the concentration serum of cefpodoxime
When cefpodoxime is used together with bismuth subnitrate, this leads to a reduction in the concentration serum of cefpodoxime
cefpodoxime leads to a reduction in the rate of excretion of pentaerythritol tetranitrate, which leads to an increased level of serum
cefpodoxime leads to a reduction in the rate of excretion of potassium acetate, which leads to an increased level of serum
cefpodoxime leads to a reduction in the rate of excretion of nitric oxide, which leads to an increased level of serum
When cefpodoxime is used together with difenpiramide, this leads to enhanced risk or seriousness of nephrotoxicity
cefpodoxime: it may decrease the excretion rate of isepamicin
cefpodoxime's serum concentration may be reduced when it is combined with almasilate
When both drugs are combined, there may be an increased risk or severity of adverse effects
demeclocycline reduces the effects of bactericidal agents
doxycycline reduces the effects of bactericidal agents
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cefpodoxime might lead to a reduction in the rate of excretion of telavancin, potentially leading to elevated levels of serum
Adverse drug reactions
Frequency Defined
>10%
Diaper rash (12.1%)
Diarrhea in infants and toddlers (15.4%)
1-10%
Vaginal infection (3.1%)
Vomiting (1.1-2.1%)
Headache (1.1%)
Diarrhea (7.4%)
Nausea (3.8%)
Abdominal pain (1.6%)
Rash (1.4%)
Pregnancy warnings:
Pregnancy category: B
Lactation:
Excreted into human milk is known
Pregnancy Categories:
Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.
Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Patient Information Leaflet
Generic Name: cefpodoxime
Why do we use cefpodoxime?
cefpodoxime is a Cephalosporins, 3rd Generation used for Community-Acquired Pneumonia.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
